Your browser doesn't support javascript.
loading
What do we know about managing Dupuytren's disease cost-effectively?
Dritsaki, Melina; Rivero-Arias, Oliver; Gray, Alastair; Ball, Catherine; Nanchahal, Jagdeep.
Afiliação
  • Dritsaki M; Oxford Clinical Trials Research Unit, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK. melina.dritsaki@ndorms.ox.ac.uk.
  • Rivero-Arias O; National Perinatal Epidemiology Unit (NPEU), Nuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, UK.
  • Gray A; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, UK.
  • Ball C; Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7FY, UK.
  • Nanchahal J; Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7FY, UK.
BMC Musculoskelet Disord ; 19(1): 34, 2018 01 25.
Article em En | MEDLINE | ID: mdl-29370792

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Análise Custo-Benefício / Gerenciamento Clínico / Contratura de Dupuytren Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Health_economic_evaluation / Health_technology_assessment / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Análise Custo-Benefício / Gerenciamento Clínico / Contratura de Dupuytren Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Health_economic_evaluation / Health_technology_assessment / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article